Osivax
Lyon, France
Purpose
to evaluate breadth and duration of protection conferred by OVX836 against seasonal and highly pathogenic influenza strains, informing its potential as a vaccine for long-term prevention of seasonal and pandemic influenza
Division
Global Health
Date
February 2023
Region Served
GLOBAL
Committed amount
$1,124,202
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
43
Grantee location
Lyon, France
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.